Secant Technologies

What Secant Technologies does

Secant Group (operating as Secant Technologies at secant.com) is a privately held biomaterials and contract manufacturing company that designs and produces custom-engineered implantable medical textiles, proprietary biodegradable polymers, and finished combination products for medical device OEMs, pharmaceutical companies, and research institutions. The company's core technology platform comprises three patented polymer systems — Poly(glycerol sebacate) (PGS) and PGSU for tissue engineering and regenerative medicine, and the Hydralese (poly(glycerol ester urethanes)) platform for long-acting drug delivery — combined with three primary textile-forming technologies (weaving, knitting, braiding) and an extensive set of post-processing capabilities including laser cutting, ultrasonic welding, and coating. These capabilities are delivered through a vertically integrated 3-step Integrated Product Development Process spanning feasibility, prototyping, and process validation.

The company operates from three Pennsylvania facilities totaling more than 150,000 sq. ft., including ISO 14644 Class 7 and 8 cleanrooms and an ITAR-compliant aerospace manufacturing line, and is FDA-registered and ISO 13485:2016 certified. Customer-facing revenue streams include custom medical device component manufacturing (one-time licensing of design and production know-how), biomaterials licensing and development (royalties from PGS, PGSU, and Hydralese), and contract manufacturing services delivered through sister company SanaVita Medical. Pricing is quote-based and project-specific, with no public pricing, and the go-to-market relies on enterprise field sales, custom product inquiry forms, and presence at major medical device conferences (COMPAMED, MD&M West, PODD, CRS).

Secant Group operates as a wholly-owned subsidiary of Solesis, a strategic operating company that also encompasses Polyzen (polymer films and coatings), SanaVita Medical (FDA-registered contract manufacturing), and Charter Medical. The company is targeting geographic expansion with a new manufacturing site in Costa Rica, and is investing in adjacent verticals such as ocular drug delivery under the Hydralese platform.

Name

Secant Technologies

Legal name

Secant Group, LLC

Website

https://secant.com

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

101–250 employees

Short description

Secant Group (operating as Secant Technologies) is a privately held biomaterials company that designs and manufactures custom-engineered implantable medical textiles, proprietary biodegradable polymers (PGS, PGSU, Hydralese), and finished combination products for medical device OEMs, pharmaceutical companies, and research institutions across cardiovascular, neurovascular, orthopedic, and general surgery applications.

Ownership category

akta.pro rank

Headquarters

HQ city

Telford

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Custom Medical Device Component Manufacturing: Secant Group designs and manufactures custom-engineered textile components and biomaterials for medical device OEMs. Revenue is generated through development fees, prototyping, and scale-up production contracts for implantable medical textiles, polymers, and hybrid solutions across cardiovascular, general surgery, neurovascular, and orthopedic applications.
2. Biomaterials Licensing and Development: Licensing of proprietary polymer platforms (PGS, PGSU, Hydralese) for drug delivery and tissue engineering applications. Custom formulation development and characterization services for pharmaceutical and medical device customers.
3. Contract Manufacturing Services: Through sister company SanaVita Medical, provides FDA-registered ISO 13485:2016 certified contract manufacturing including cleanroom assembly, component coating, finishing, sterilization management, and regulatory support for medical devices and combination products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Secant Technologies (Secant Group) is a biomaterials manufacturer that designs, develops, and produces custom-engineered implantable medical textiles, proprietary biodegradable polymer platforms (PGS, PGSU, Hydralese), and technical textiles for aerospace and filtration. It sells these components and materials to medical device OEMs, pharmaceutical companies, and research institutions, while providing integrated design, prototyping, manufacturing, post-processing, contract manufacturing, and quality assurance services under the Solesis umbrella.

Product overview

Secant Group is a biomaterials company offering a portfolio of advanced implantable medical textiles, biodegradable polymers, and contract manufacturing services. The core offerings include Hydralese (a polymer platform for long-acting drug delivery), Poly(glycerol sebacate) (PGS) for tissue engineering, and custom-engineered biomedical textiles for cardiovascular, general surgery, neurovascular, and orthopedic applications. The company also provides industrial textiles for aerospace communications and filtration. Services include design & development, manufacturing, post-processing, and quality assurance. The company operates as part of the Solesis family alongside sister companies Polyzen, SanaVita Medical, and Charter Medical.

Differentiator

Problem solved

Functional benefit

Brands

• Hydralese: Novel polymer platform for controlled delivery of active pharmaceutical and biopharmaceutical ingredients (API/ABI). A library of flexible elastomers comprised of poly(glycerol ester urethanes) (PGEUs) for multi-month controlled drug delivery.
• PGS (Poly(glycerol sebacate))
• PGSU (Poly(glycerol sebacate) urethane)

Products and services

• Hydralese Polymer Platform

Quantifiable outcome

• Degradation timeframe of 3 to 12+ months for Hydralese polymer
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core, supporting and strategic.

• SanaVita MedicalcoreStrategic or Co-development PartnerSanaVita Medical is a fully integrated contract manufacturer and sister company under the Solesis family. It provides FDA-registered ISO 13485:2016 certified manufacturing with over 10,000 sq. ft. of ISO 7 cleanroom space for final device assembly and finishing. Performs development and finishing of medical devices and combination products independently or in partnership with Secant Group.
• PolyzencoreStrategic or Co-development PartnerPolyzen is a sister company providing polymer expertise including films, coatings, laminates, and custom processing techniques. Together with Secant Group (textiles), Polyzen forms the foundation of Solesis' medtech capabilities for integrating materials into component solutions for medical devices and delivery systems.
• Charter MedicalsupportingStrategic or Co-development PartnerCharter Medical is a sister company within the Solesis family of companies providing advanced solutions that complement Secant Group's biomedical textiles and polymer offerings for life science companies.
• Nationwide Children's HospitalstrategicStrategic or Co-development PartnerCollaboration to advance breakthrough cardiovascular technology using Secant Group's PGS tissue engineering polymer platform. Joint development of regenerative cardiovascular solutions including vascular grafts and bioresorbable patches.
• CytexOrthostrategicStrategic or Co-development PartnerCytexOrtho partnered with Secant Group and SanaVita Medical for textile design and contract manufacturing solutions that advanced an orthopedic implant to clinical trials.
• Polyzen (COMPAMED Partnership)supportingGTM or Marketing PartnerExhibiting partnership at COMPAMED trade fair where Secant Group and Polyzen showcase combined biomaterials capabilities under the Solesis brand.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Teleflex Medical OEM: Teleflex's Medical OEM division supplies custom-engineered extrusions, textiles, and biomaterial components to medical device OEMs across cardiovascular, structural heart, and surgical applications, directly overlapping Secant's implantable textile and component business.
• Bally Ribbon Mills: Bally Ribbon Mills designs and weaves specialty narrow fabrics, biomedical textiles, and 3D braided structures for medical, aerospace, and industrial markets, directly comparable to Secant's woven/knit/braided medical textile portfolio.
• Scapa Healthcare: Scapa Healthcare develops and manufactures custom skin-contact adhesives, wound care dressings, and biomedical materials for medical device OEMs, overlapping Secant's implantable textile and post-processing capabilities for surgical and wound care applications.
• U.S. BioDesign: U.S. BioDesign is a contract developer and manufacturer of biomedical textiles and implantable components, directly comparable to Secant in serving cardiovascular and surgical OEMs with custom woven/knit/braided textile solutions.
• Confluent Medical Technologies: Confluent Medical specializes in nitinol and polymer-based components and finished devices for structural heart, vascular, and electrophysiology applications, overlapping with Secant's cardiovascular textile and implantable device component offerings.

Broad incumbents

• DuPont Biomedical (DuPont Specialty Products): DuPont supplies biomedical-grade polymers and fibers (including Tyvek and specialty biomaterials) used in implantable and combination products, competing with Secant's polymer and textile offerings at much larger scale as a diversified materials incumbent.
• DSM Biomedical (Royal DSM): DSM Biomedical is a leading biomaterials supplier of resorbable polymers (including Dyneema Purity, Bionate, and bioabsorbable grades) for implantable devices and drug delivery, competing with Secant's Hydralese, PGS, and PGSU platforms in the biomaterials licensing space.
• Evonik Health Care: Evonik supplies specialty bioresorbable polymers (RESOMER) for medical device and drug delivery applications, competing with Secant's PGS, PGSU, and Hydralese polymer platforms in the implantable biomaterials market.
• Trelleborg Healthcare & Medical: Trelleborg Healthcare & Medical manufactures precision polymer and silicone components, including drug-eluting and bioresorbable implantable parts for medical device OEMs, overlapping with Secant's polymer and contract manufacturing capabilities.

Emerging players

• PolyMed (Poly-Med Inc.): Poly-Med is a specialized biomaterials company focused on bioresorbable polymers and fibers for medical textiles, tissue engineering, and drug delivery, directly comparable to Secant's resorbable polymer and textile offerings at a smaller scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC0d2EKtAwaMSbczAWUf2SFg
• LinkedInlinkedin.com/company/secant-medical-inc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Secant Technologies